Tech Company M&A Transactions
CNS Therapeutics Acquisition
On 9/25/2012, CNS Therapeutics was acquired by Covidien. Financial terms set the valuation at $100 million.
Transaction Overview
Company Name
Acquired By
Announced On
9/25/2012
Transaction Type
M&A
Amount
$100,000,000
M&A Terms
Additional financial terms of the transaction were not disclosed by the parties.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
332 Minnesota Street
Saint Paul, MN 55101
USA
Saint Paul, MN 55101
USA
Phone
Undisclosed
Website
Email Address
Overview
CNS Therapeutics develops and brings to market safe, high-quality pharmaceuticals for site-specific delivery to the central nervous system. Gablofen (baclofen injection) marks first breakthrough for CNS Therapeutics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Foster
Chief Financial Officer
Scott Bronson
Chief Scientific Officer
Richard Penn
VP - Administration
Scott Bronson
VP - Marketing
Michael Post
VP - Sales
David Youngberg
Browse more venture capital transactions:
Prev: 9/25/2012: iMemories venture capital transaction
Next: 9/25/2012: FreePriceAlerts venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs